Burn shock.
D000818:Animals; D001775:Blood Circulation; D002056:Burns / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D002199:Capillary Permeability; D002395:Catecholamines / Q000378:metabolism; D003911:Dextrans / Q000627:therapeutic use; D004285:Dogs; D004487:Edema / Q000209:etiology; D006439:Hemodynamics; D006636:Histamine Release; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D007213:Indomethacin / Q000627:therapeutic use; D007263:Infusions, Parenteral; D012157:Mononuclear Phagocyte System / Q000378:metabolism; D009747:Nutritional Physiological Phenomena; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D011453:Prostaglandins / Q000096:biosynthesis; D018805:Sepsis / Q000209:etiology; D012769:Shock / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D016038:Skin Transplantation; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous
D002395:Catecholamines; D003911:Dextrans; D011453:Prostaglandins; D010100:Oxygen; D007213:Indomethacin